Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 9, Pages 4344
Publisher
MDPI AG
Online
2021-04-22
DOI
10.3390/ijms22094344
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The interleukin-1 family cytokines in psoriasis: pathogenetic role and therapeutic perspectives
- (2021) Helena Iznardo et al. Expert Review of Clinical Immunology
- Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study
- (2021) Ulrich Mrowietz et al. Dermatology and Therapy
- Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments
- (2020) Magdalena Misiak-Galazka et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis
- (2020) Silke Frey et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
- (2020) April W. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of Neutrophils in Psoriasis
- (2020) Wen-Ming Wang et al. Journal of Immunology Research
- “Autoinflammatory psoriasis”—genetics and biology of pustular psoriasis
- (2020) Ranjitha Uppala et al. Cellular & Molecular Immunology
- Enhanced IL-36R signaling promotes barrier impairment and inflammation in skin and intestine
- (2020) Zaruhi Hovhannisyan et al. Science Immunology
- Cathepsin G cleaves and activates IL-36γ and promotes the inflammation of psoriasis
- (2019) Jing Guo et al. Drug Design Development and Therapy
- Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
- (2019) Hervé Bachelez et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential
- (2019) Marie-Astrid Boutet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-38 Ameliorates Skin Inflammation and Limits IL-17 Production from γδ T Cells
- (2019) Yingying Han et al. Cell Reports
- The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
- (2019) Madonna et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis
- (2019) Viktor Todorović et al. Scientific Reports
- An update on generalized pustular psoriasis
- (2019) Melinda J. Gooderham et al. Expert Review of Clinical Immunology
- Interleukin-36 promotes systemic Type-I IFN responses in severe forms of psoriasis
- (2019) Marika Catapano et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis
- (2019) Marie-Astrid Boutet et al. RHEUMATOLOGY
- The genetic basis for most patients with pustular skin disease remains elusive
- (2018) R. Mössner et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical and genetic differences between pustular psoriasis subtypes
- (2018) Sophie Twelves et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Unopposed IL-36 Activity Promotes Clonal CD4 + T-Cell Responses with IL-17A Production in Generalized Pustular Psoriasis
- (2018) Akiko Arakawa et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies
- (2018) Farzad Alinaghi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Extracellular Neutrophil Proteases Are Efficient Regulators of IL-1, IL-33, and IL-36 Cytokine Activity but Poor Effectors of Microbial Killing
- (2018) Danielle M. Clancy et al. Cell Reports
- IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis
- (2018) Charlie Bridgewood et al. Frontiers in Immunology
- IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis
- (2018) Zhi Su et al. EXPERIMENTAL DERMATOLOGY
- IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment
- (2018) Laura Mercurio et al. Cell Death & Disease
- Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines
- (2017) Danielle M. Clancy et al. FEBS Journal
- IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
- (2017) Andrew Johnston et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- European consensus statement on phenotypes of pustular psoriasis
- (2017) A.A. Navarini et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies
- (2017) Rajkumar Ganesan et al. mAbs
- Psoriatic Arthritis
- (2017) Christopher T. Ritchlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target
- (2017) Satveer K. Mahil et al. Science Translational Medicine
- The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases
- (2016) Patrick T. Walsh et al. Annals of the New York Academy of Sciences
- IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
- (2016) H. Agerstam et al. BLOOD
- CD4+T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm
- (2016) Kiyoshi Hirahara et al. INTERNATIONAL IMMUNOLOGY
- Mutation analysis ofIL36RNgene in Japanese patients with palmoplantar pustulosis
- (2016) Toshifumi Takahashi et al. JOURNAL OF DERMATOLOGY
- Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist
- (2016) Tom Macleod et al. Scientific Reports
- Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines
- (2016) Conor M. Henry et al. Cell Reports
- Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients
- (2015) Ting-Shun Wang et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis
- (2015) Safia Hussain et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14 , but Not with Loss-of-Function Mutations in IL36RN in European Patients
- (2015) Rotraut Mössner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions
- (2015) Cem Gabay et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Psoriasis
- (2015) Wolf-Henning Boehncke et al. LANCET
- Alarmin Function of Cathelicidin Antimicrobial Peptide LL37 through IL-36γ Induction in Human Epidermal Keratinocytes
- (2014) Na Li et al. JOURNAL OF IMMUNOLOGY
- Psoriasis prevalence among adults in the United States
- (2014) Tara D. Rachakonda et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Rare Pathogenic Variants in IL36RN Underlie a Spectrum of Psoriasis-Associated Pustular Phenotypes
- (2013) Niovi Setta-Kaffetzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium
- (2012) Silke Frey et al. ANNALS OF THE RHEUMATIC DISEASES
- Psoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalk
- (2012) Luigi Tortola et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis
- (2011) Alexandros Onoufriadis et al. AMERICAN JOURNAL OF HUMAN GENETICS
- IL-36R ligands are potent regulators of dendritic and T cells
- (2011) S. Vigne et al. BLOOD
- Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity
- (2011) Jennifer E. Towne et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis
- (2011) Yijun Carrier et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search